Cormorant Asset Management LP 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management LP | 4,639,998 9.790% | 179,998 (+4.04%) | Filing |
| 2021-02-16 3:06 pm Purchase | 2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management LP | 4,460,000 9.970% | 1,080,630 (+31.98%) | Filing |
| 2020-07-06 4:01 pm Purchase | 2020-06-23 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management LP | 3,379,370 8.760% | 3,379,370 (New Position) | Filing |